How Type 2 Diabetes Medications Actually Work

Why one person thrives on one medication and another person feels wrecked.

Here’s something most people aren’t told upfront: Type 2 diabetes medications don’t all do the same thing.

They target different breakdowns in the glucose system—some help insulin work better, some push the pancreas harder, some slow digestion, and some tell the kidneys to dump sugar.

That’s why a medication can feel like a miracle for one person and absolute hell for another.

  • What This Article Is Really Saying:

    Not: “Don’t take meds.”

    But: “Know what problem the medication is trying to solve.
    Ask Questions.”


    When you understand this, you can stop blaming yourself and start collaborating intelligently with your providers.

    Questions to Ask Your Provider:

    “What part of my glucose system is
    this medication targeting?”

    “What signs would tell us this
    isn’t the right match?”

    “How does stress or sleep affect
    how this medication works?”

    “What should we reassess if side effects show up?”

    The Missing Conversation:

    Most medication plans don’t assess:

    Cortisol levels

    Sleep quality

    Chronic stress load

    Nervous system state

    Yet stress hormones can:

    Suppress insulin release

    Increase liver glucose output

    Worsen medication side effects

    Which is why a med that technically works can still feel intolerable—until nervous system regulation improves.

    The RE²A²CH Method starts with a simple truth most treatment plans overlook: the nervous system is part of glucose regulation. Medications can improve signaling, insulin release, or glucose disposal—but chronic stress can quietly counteract those benefits.

    When cortisol is high, the body prioritizes survival over balance. This is why the “right” medication can feel wrong until regulation improves. REACH supports women in reducing stress load, restoring safety in the body, and understanding their patterns—so medication becomes a support, not a struggle.

  • 1. Metformin

    What it targets: Insulin resistance (primarily in the liver)

    What it does:

    Reduces how much glucose the liver
    releases Improves insulin sensitivity

    Slightly reduces glucose absorption from food

    Why it’s often first-line:

    Long safety record

    Doesn’t usually cause weight gain

    Low risk of hypoglycemia

    Why it can be brutal for some:

    GI distress (nausea, diarrhea, cramps)

    Can worsen fatigue if cortisol, gut health, or nutrient status is already compromised

    Key question to ask:
    “Is my issue more insulin resistance—or insulin production?


    2. Sulfonylureas (e.g., Glimepiride)

    What they target: Insulin production (Phase 1 response)

    What they do:

    Signal the pancreas to release more insulin

    Why they help some people dramatically:

    Especially useful when the pancreas can make insulin but isn’t releasing it effectively

    Risks & cautions:

    Can cause low blood sugar

    Can increase pancreatic workload over time

    My lived insight (important):
    For some women—especially those with stress-suppressed insulin release—this can feel like the missing piece until cortisol and nervous system load
    are addressed.

    Key question to ask:

    “Do I struggle more with insulin release or insulin resistance? Or both?"

  • 3. GLP-1 Receptor Agonists injectables)

    What they target: Appetite signaling, insulin response, digestion speed

    What they do:

    Increase insulin release only when glucose is present

    Slow stomach emptying (smaller spikes)

    Reduce appetite signaling in the brain

    Why they’re powerful:

    Improve glucose control and weight regulation

    Lower cardiovascular risk

    Why they’re not neutral:

    Can cause nausea, fatigue, muscle loss if nutrition is inadequate

    Appetite suppression ≠ metabolic healing by itself

    Key question to ask:

    “Is appetite dysregulation part of my glucose issue—or a response to stress?”

    4. SGLT-2 Inhibitors

    What they target: Glucose excretion (via kidneys)

    What they do:

    Force excess glucose out through urine

    Pros:

    Lower blood sugar independently of insulin

    Cardiovascular and kidney benefits for some

    Cons:

    Increased risk of dehydration and infections

    Doesn’t address underlying insulin signaling

    Key question to ask:

    “Is this helping regulation—or just removing excess?”

    5. DPP-4 Inhibitors (GLP-1 support, milder)

    What they target: Natural incretin hormones

    What they do:

    Help your own GLP-1 last longer

    Why they’re gentler:

    Less appetite suppression

    Fewer GI effects

    Trade-off:

    More modest glucose lowering





Contact form